Home/Filings/4/0001104659-20-080809
4//SEC Filing

BOSCH MARNIX L 4

Accession 0001104659-20-080809

CIK 0001072379other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 9:55 PM ET

Size

5.8 KB

Accession

0001104659-20-080809

Insider Transaction Report

Form 4
Period: 2020-07-02
BOSCH MARNIX L
Chief Technical Officer
Transactions
  • Award

    Options to purchase Common Stock, par value $0.001

    2020-07-02+16,630,72616,630,726 total
    Exercise: $0.25From: 2020-12-01Exp: 2030-12-01Common Stock, par value $0.001 (16,630,726 underlying)
Footnotes (1)
  • [F1]These options were awarded in part for service during the last 2 years. However, the documents to implement and issue (grant) them have not been executed until now. The $0.25 exercise price was determined with reference to the pricing for unrelated investors at the time of approval, which was the trailing 10-day average closing market price of the Company's stock, which was about $0.22. These options are subject to certain vesting requirements. They are also suspended and will not become exercisable until December 1, 2020.

Issuer

NORTHWEST BIOTHERAPEUTICS INC

CIK 0001072379

Entity typeother

Related Parties

1
  • filerCIK 0001253933

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 9:55 PM ET
Size
5.8 KB